An introduction to epigenetics

Advances in Experimental Medicine and Biology

Volumn 711, Issue , 2011, Pages 1-11

  Ballestar, Esteban ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TRANSCRIPTION FACTOR RUNX1;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CENTROMERE; CHROMATIN IMMUNOPRECIPITATION; CPG ISLAND; DNA METHYLATION; DNA MODIFICATION; DNA REPLICATION; EPIGENETICS; GENE FREQUENCY; GENE LOCUS; GENE REPRESSION; GENE SILENCING; GENOME IMPRINTING; HISTONE ACETYLATION; HUMAN; ISOMERIZATION; NONHUMAN; NUCLEAR REPROGRAMMING; PHASE TRANSITION; PRIORITY JOURNAL; PROMOTER REGION; ANIMAL; GENETIC EPIGENESIS; GENETICS; NEOPLASM; REVIEW;

EUKARYOTA;

ANIMALS; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; NEOPLASMS;

EID: 79958285518     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-8216-2_1     Document Type: Article

References (79)

1. Jaenisch R, Bird A. Epigenetic regulation of gene expression, how the genome integrates intrinsic and environmental signals. Nat Genet 2003; 33, Suppl:245-254. (Pubitemid 36278835)
2. Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987; 196:261-282. (Pubitemid 17122132)
3. Davuluri RV, Grosse I, Zhang MQ. Computational identification of promoters and first exons in the human genome. Nat Genet 2001; 29:412-417. (Pubitemid 34326691)
4. Marino-Ramirez L, Spouge JL, Kanga GC et al. Statistical analysis of over-represented words in human promoter sequences. Nucleic Acids Res 2004; 32:949-958. (Pubitemid 38854697)
5. Robertson KD, Wolffe AP. DNA methylation in health and disease. Nat Rev Genet 2000; 1:11-19.
6. Espada J, Ballestar E, Fraga MF et al. Human DNMT1 is essential to maintain the histone H3 modification pattern. J Biol Chem 2004; 279:37175-37184. (Pubitemid 39129068)
7. Siegfried Z, Cedar H. DNA methylation, a molecular lock. Curr Biol 1997; 7:R305-307.
8. Futscher BW, Oshiro MM, Wozniak RJ et al. Role for DNA methylation in the control of cell type specific maspin expression. Nature Genet 2002; 31:175-179.
9. Song F, Smith JF, Kimura MT et al. Association of tissue-specific differentially methylated regions (TDMs) with differential gene expression. Proc Natl Acad Sci USA 2005; 102:3336-3341. (Pubitemid 40328046)
10. Reik W, Collick A, Norris ML et al. Genomic imprinting determines methylation of parental alleles in transgenic mice. Nature 1987; 328:248-251. (Pubitemid 17108272)
11. Wolf SF, Migeon BR. Studies of X chromosome DNA methylation in normal human cells. Nature 1982; 295:667-671. (Pubitemid 12116137)
12. Clark SJ, Harrison J, Paul CL et al. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994; 22:2990-2997. (Pubitemid 24260626)
13. Roberts RJ, Cheng X. Base flipping. Annu Rev Biochem 1998; 67:181-198. (Pubitemid 28411128)
14. Goll MG, Bestor TH. Eukaryotic cytosine methyltransferases. Annu Rev Biochem 2005; 74:481-514. (Pubitemid 40995515)
15. Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science 2001; 293:1089-1093. (Pubitemid 32758081)
16. WilsonCB, Merkenschlager M. Chromatin structure and gene regulation in T-cell development and function. Curr Opin Immunol 2006; 18:143-151. (Pubitemid 43327295)
17. Zhu JK. Active DNA demethylation mediated by DNA glycosylases. Annu Rev Genet 2009; 43:143-166.
18. Bhutani N, Brady JJ, Damian M et al. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 2010; 463:1042-1047.
19. Popp C, Dean W, Feng S et al. Genome-wide erasure of DNA methylation in mouse primordial germ cells is affectedby AID deficiency. Nature 2010; 463:1101-1105.
20. Wang Y, Fischle W, Cheung W et al. Beyond the double helix, writing and reading the histone code. Novartis Found Symp 2004; 259:3-17.
21. Chahal SS, Matthews HR, Bradbury EM. Acetylation of histone H4 and its role in chromatin structure and function. Nature 1980; 287:76-79.
22. Rundlett SE, Carmen AA, Suka N et al. Transcriptional repression by UME6 involves deacetylation of lysine 5 of histone H4 by RPD3. Nature 1998; 392:831-835. (Pubitemid 28225326)
23. Shogren-Knaak M, Ishii H, Sun JM et al. Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 2006; 311:844-847. (Pubitemid 43228847)
24. Rao B, Shibata Y, Strahl BD et al. Demethylation of histone H3 at lysine 36 demarcates regulatory and nonregulatory chromatin genome-wide. Mol Cell Biol 2005; 25:9447-9459. (Pubitemid 41507845)
25. Lachner M, O'Carroll D, Rea S et al. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 2001; 410:116-120. (Pubitemid 32225847)
26. Schotta G, Lachner M, Sarma K et al. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev 2004; 18:1251-1262. (Pubitemid 38720593)
27. Santos-Rosa H, Schneider R, Bannister AJ et al. Active genes are tri-methylated at K4 of histone H3. Nature 2002; 419:407-411.
28. Bauer UM, Daujat S, Nielsen SJ et al. Methylation at arginine 17 of histone H3 is linked to gene activation. EMBO Rep 2002; 3:39-44. (Pubitemid 34144813)
29. Bannister AJ, Zegerman P, Partridge JF et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 2001; 410(6824):120-124. (Pubitemid 32225848)
30. Karachentsev D, SarmaK, Reinberg D et al. PR-Set7-dependent methylation ofhistone H4Lys 20 functions in repression of gene expression and is essential for mitosis. Genes Dev 2005; 19:431-435. (Pubitemid 40256274)
31. Sterner DE, Berger SL. Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 2000; 64:435-459. (Pubitemid 30412680)
32. Zhang Y, Reinberg D. Transcription regulation by histone methylation, interplay between different covalent modifications of the core histone tails. Genes Dev 2006; 15:2343-2360. (Pubitemid 32899739)
33. Nowak SJ, Corces VG. Phosphorylation ofhistone H3, a balancing act between chromosome condensation and transcriptional activation. Trends Genet 2004; 20:214-220. (Pubitemid 38369193)
34. Shilatifard A. Chromatin modifications by methylation and ubiquitination, implications in the regulation of gene expression. Annu Rev Biochem 2006; 75:243-269. (Pubitemid 44118033)
35. Hassa PO, Haenni SS, Elser M et al. Nuclear ADP-ribosylation reactions in mammalian cells, where are we today and where are we going? Microbiol Mol Biol Rev 2006; 70:789-829. (Pubitemid 44484693)
36. Nathan D, Ingvarsdottir K, Sterner DE et al. Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modifications. Genes Dev 2006; 20:966-976.
37. Cuthbert GL, Daujat S, Snowden AW et al. Histone deimination antagonizes arginine methylation. Cell 2004; 118:545-553. (Pubitemid 39179708)
38. Wang Y, Wysocka J, Sayegh J et al. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 2004; 306:279-283. (Pubitemid 39336873)
39. Nelson CJ, Santos-Rosa H, Kouzarides T. Proline isomerization ofhistone H3 regulates lysine methylation and gene expression. Cell 2006; 126:905-916. (Pubitemid 44310777)
40. Burgers WA, Fuks F, Kouzarides T. DNA methyltransferases get connected to chromatin. Trends Genet 2002; 18:275-277. (Pubitemid 34607108)
41. Hendrich B, Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 1998; 18:6538-6547. (Pubitemid 28500543)
42. Ballestar E, Wolffe AP. Methyl-CpG-binding proteins, targeting specific gene repression. Eur J Biochem 2001; 268:1-6. (Pubitemid 32052241)
43. Vire E, Brenner C, Deplus R et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 2006; 439:871-874. (Pubitemid 43255707)
44. Schlesinger Y, Straussman R, Keshet I et al. Polycomb-mediated methylation on Lys27 of histone H3 premarks genes for de novo methylation in cancer. Nat Genet 2007; 39:232-236. (Pubitemid 46184355)
45. Mohn F, Weber M, Rebhan M et al. Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol Cell 2008; 30:755-766.
46. Feil R. Environmental and nutritional effects on the epigenetic regulation of genes. Mutat Res 2006; 600:46-57.
47. Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301:89-92. (Pubitemid 13154475)
48. Ehrlich M. DNA methylation in cancer, too much, but also too little. Oncogene 2002; 21:5400-5413. (Pubitemid 34983477)
49. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415-428. (Pubitemid 34587077)
50. Costello JF, Fruhwald MC, Smiraglia DJ et al. Aberrant CpG-island methylation has nonrandom and tumour-type-specific patterns. Nat Genet 2000; 24:132-138. (Pubitemid 30094712)
51. Esteller M, Corn PG, Baylin SB et al. A gene hypermethylation profile of human cancer. Cancer Res 2001a; 61:3225-3229. (Pubitemid 32695003)
52. Mokarram P, Kumar K, Brim H et al. Distinct high-profile methylated genes in colorectal cancer. PLoS One 2009; 4:e7012.
53. Martinez R, Martin-Subero JI, Rohde V et al. A microarray-based DNA methylation study of glioblastoma multiforme. Epigenetics 2009; 4:255-264.
54. Esteller M, Tortola S, Toyota M et al. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res 2000; 60:129-133. (Pubitemid 30058742)
55. Esteller M, Lluis Catasus, Matias-Guiu X et al. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. Am J Pathol 1999; 155:1767-1772.
56. Fleisher AS, Esteller M, Wang S et al. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 1999; 59:1090-1095. (Pubitemid 29135970)
57. Pegg AE, Dolan ME, Moschel RC. Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase. Prog Nucleic Acid Res Mol Biol 1995; 51:167-223.
58. Esteller M, Hamilton SR, Burger PC et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999; 59:793-797. (Pubitemid 29086728)
59. Esteller M, Toyota M, Sanchez-Cespedes M et al. Inactivation ofthe DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 2000; 60:2368-2371. (Pubitemid 30262424)
60. Esteller M, Risques RA, Toyota M et al. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G,C to A,T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res 2001; 61:4689-4692. (Pubitemid 32691877)
61. Keshet I, Schlesinger Y, Farkash S et al. Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat Genet 2006; 38:149-153. (Pubitemid 43177227)
62. Ballestar E, Paz MF, Valle L et al. Methyl-CpG binding proteins identify novel sites ofepigenetic inactivation in human cancer. EMBO J 2003; 22:6335-6345. (Pubitemid 37522590)
63. Fraga MF, Ballestar E, Villar-Garea A et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 2005; 37:391-400.
64. Seligson DB, Horvath S, Shi T et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 2005; 435:1262-1266. (Pubitemid 40943093)
65. Pfister S, Rea S, Taipale M et al. The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma. Int J Cancer 2008; 122:1207-1213. (Pubitemid 351287218)
66. Tryndyak VP, Kovalchuk O, Pogribny IP. Loss ofDNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression ofDNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins. Cancer Biol Ther 2006; 5:65-70. (Pubitemid 43234980)
67. Di Croce L. Chromatin modifying activity of leukaemia associated fusion proteins. Hum Mol Genet 2005; 14 Spec No 1:R77-84. (Pubitemid 40542623)
68. Kondo T, Bobek MP, Kuick R et al. Whole-genome methylation scan in ICF syndrome, hypomethylation of nonsatellite DNA repeats D4Z4 and NBL2. Hum Mol Genet 2000; 9:597-604. (Pubitemid 30154018)
69. Matarazzo MR, Boyle S, D'Esposito M et al. Chromosome territory reorganization in a human disease with altered DNA methylation. Proc Natl Acad Sci USA 2007; 104:16546-16551. (Pubitemid 350211055)
70. Amir RE, Van den Veyver IB, Wan M et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999; 23:185-188. (Pubitemid 29455390)
71. Ballestar E, Ropero S, Alaminos M et al. The impact of MECP2 mutations in the expression patterns of Rett syndrome patients. Hum Genet 2005; 116:91-104. (Pubitemid 40057920)
72. Yasui DH, Peddada S, Bieda MC et al. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci USA 2007; 104:19416-19421.
73. van Overveld PG, Lemmers RJ, Sandkuijl LA et al. Hypomethylation ofD4Z4 in 4q-linked and non4q-linked facioscapulohumeral muscular dystrophy. Nat Genet 2003; 35:315-317. (Pubitemid 37486913)
74. Arnaud P, Feil R. Epigenetic deregulation of genomic imprinting in human disorders and following assisted reproduction. 2005; 75:81-97.
75. Petronis A. Epigenetics and twins, three variations on the theme. Trends Genet 2006; 22:347-350. (Pubitemid 44015966)
76. Fraga MF, Ballestar E, Paz MF et al. Epigenetic Differences Arise During the Lifetime of Monozygotic Twins. Proc Natl Acad Sci USA 2005; 102:10604-10609. (Pubitemid 41061601)
77. Javierre BM, Fernandez AF, Richter J et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 2010; 20:170-179.
78. Baranzini SE, Mudge J, van Velkinburgh JC et al. Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature 2010; 464:1351-1356.
79. Miao F, Smith DD, Zhang L et al. Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes. Diabetes 2008; 57:3189-3198.